Literature DB >> 28901947

A robust optimisation approach accounting for the effect of fractionation on setup uncertainties.

Matthew Lowe1, Adam Aitkenhead, Francesca Albertini, Antony J Lomax, Ranald I MacKay.   

Abstract

Proton plans are subject to a number of uncertainties which must be accounted for to ensure that they are delivered safely. Misalignment resulting from residual errors in daily patient positioning can result in both a displacement and distortion of dose distributions. This can be particularly important for intensity modulated proton therapy treatments where the accurate alignment of highly modulated fields may be required to deliver the intended treatment. A number of methods to generate plans that are robust to these uncertainties exist. These include robust optimisation approaches which account for the effect of uncertainties on the dose distribution within the optimisation process. However, robustness to uncertainty comes at the cost of plan quality. For this reason, it is important that the uncertainties considered are realistic. Existing approaches to robust optimisation have neglected the role of fractionated treatment deliveries in reducing the uncertainties that result from random setup errors. Here, a method of robust optimisation which accounts for this effect is presented and is evaluated using a 2D planning environment. The optimisation algorithm considers the dose in the estimated upper and lower bounds of the dose distribution under the effect of setup and range errors. A comparison with plans robustly optimised without consideration of the effect of fractionation and conventionally optimised plans is presented. Fractionation incorporated robust optimisation demonstrates a reduced sensitivity to uncertainty compared to conventionally optimised plans and a reduced integral dose compared to robustly optimised plans.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28901947     DOI: 10.1088/1361-6560/aa8c58

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  3 in total

Review 1.  Advances in radiotherapy technology for pediatric cancer patients and roles of medical physicists: COG and SIOP Europe perspectives.

Authors:  Chia-Ho Hua; Anthony E Mascia; Enrica Seravalli; Antony J Lomax; Klaus Seiersen; Kenneth Ulin
Journal:  Pediatr Blood Cancer       Date:  2021-05       Impact factor: 3.167

2.  Long-time clinical experience in patient setup for several particle therapy clinical indications: management of patient positioning and evaluation of setup reproducibility and stability.

Authors:  Rosalinda Ricotti; Andrea Pella; Barbara Tagaste; Giovanni Elisei; Giulia Fontana; Maria Bonora; Mario Ciocca; Francesca Valvo; Roberto Orecchia; Guido Baroni
Journal:  Br J Radiol       Date:  2019-11-14       Impact factor: 3.629

3.  Evaluation of plan robustness on the dosimetry of volumetric arc radiotherapy (VMAT) with set-up uncertainty in Nasopharyngeal carcinoma (NPC) radiotherapy.

Authors:  Zhen Ding; Xiaoyong Xiang; Qi Zeng; Jun Ma; Zhitao Dai; Kailian Kang; Suyan Bi
Journal:  Radiat Oncol       Date:  2022-01-03       Impact factor: 3.481

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.